Department of Neurology, The Royal Children's Hospital, Melbourne, Victoria, Australia; Division of Paediatric Neurology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
T.Y. Nelson Department of Neurology and Neurosurgery and Kids Neuroscience Centre, The Children's Hospital Westmead, Sydney, New South Wales, Australia; Children's Hospital at Westmead Clinical School, University of Sydney, Sydney, New South Wales, Australia.
Neuromuscul Disord. 2024 Apr;37:29-35. doi: 10.1016/j.nmd.2024.03.005. Epub 2024 Mar 12.
5q-associated spinal muscular atrophy (SMA) is the most common autosomal recessive neurological disease. Depletion in functional SMN protein leads to dysfunction and irreversible degeneration of the motor neurons. Over 95 % of individuals with SMA have homozygous exon 7 deletions in the SMN1 gene. Most of the remaining 4-5 % are compound heterozygous for deletion and a disease-associated sequence variant in the non-deleted allele. Individuals with SMA due to bi-allelic SMN1 sequence variants have rarely been reported. Data regarding their clinical phenotype, disease progression, outcome and treatment response are sparse. This study describes six individuals from three families, all with homozygous sequence variants in SMN1, and four of whom received treatment with disease-modifying therapies. We also describe the challenges faced during the diagnostic process and intrafamilial phenotypic variability observed between siblings.
5q 相关脊髓性肌萎缩症(SMA)是最常见的常染色体隐性神经疾病。功能性 SMN 蛋白的缺失会导致运动神经元功能障碍和不可逆转的退化。超过 95%的 SMA 患者的 SMN1 基因中存在纯合子外显子 7 缺失。其余的 4-5%大多数是缺失和非缺失等位基因中与疾病相关的序列变异的复合杂合子。由于双等位基因 SMN1 序列变异导致的 SMA 个体很少有报道。关于他们的临床表型、疾病进展、结果和治疗反应的数据很少。本研究描述了来自三个家庭的六名个体,他们均为 SMN1 纯合序列变异,其中四人接受了疾病修正治疗。我们还描述了在诊断过程中遇到的挑战,以及兄弟姐妹之间观察到的家族内表型变异性。